ERBB2 and neoplasm: The results of manual inspections showed a significant delay in tumor appearance in HER-2/Neu mice undergoing prophylactic CTX + ACT/IS treatment with respect to untreated mice, with 20% of mice being still tumor-free at 40 weeks of age (Figure 5A).